SEC Info - Syneos Health, Inc. - ‘8-K’ for 2/18/21

SEC Info℠

Home

Help

Please Sign In

Syneos Health, Inc. – ‘8-K’ for 2/18/21

On: Wednesday, 2/17/21, at 7:58pm ET · As of: 2/18/21 · For: 2/18/21 · Accession #: 1564590-21-6473 · File #: 1-36730

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/18/21  Syneos Health, Inc.               8-K:2,9     2/18/21   11:1.2M                                   ActiveDisclosure/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    248K 
 7: R1          Document and Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- synh-8k_20210218_htm                XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- synh-20210218_lab                     XML     56K 
 5: EX-101.PRE  XBRL Presentations -- synh-20210218_pre              XML     34K 
 3: EX-101.SCH  XBRL Schema -- synh-20210218                         XSD     18K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001564590-21-006473-xbrl      Zip     39K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C:

i false i 0001610950 0001610950 2021-02-18 2021-02-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i February 18, 2021

i SYNEOS HEALTH, INC.

(Exact name of registrant as specified in its charter)

i Delaware	i 001-36730	i 27-3403111
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i 1030 Sync Street

i Morrisville, i North Carolina

i 27560-5468

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: ( i 919) i 876-9300

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
i Class A Common Stock, $0.01 par value per share		i SYNH		i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section

13(a) of the Exchange Act. ☐

Item 2.02

Results of Operations and Financial Condition.

On February 18, 2021, Syneos Health, Inc. (the “Company”) issued a press release announcing its financial results for the three and twelve months ended December 31, 2020. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press release dated February 18, 2021
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			SYNEOS HEALTH, INC.

Date:	February 17, 2021	By:	/s/ *Jason Meggs*
			Name:	Jason Meggs
			Title:	Chief Financial Officer (Principal Financial Officer)

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed as of / For Period end:	2/18/21	10-K, 4
Filed on:	2/17/21	10-K
	12/31/20	10-K
		List all Filings

↑Top

Filing Submission 0001564590-21-006473 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)